Examining the expression and functional traits of TIM‐4 in PDAC, we attempted to enrich the content of the regulatory network of the immune microenvironment of PDAC and found evidence that TIM‐4 has the potential to be a target of immunotherapy to change the tumor microenvironment of PDAC. The gene discussed is TIMD4; the disease is neoplasm.